KIORA PHARMACEUTICALS, INC. (KPHMW) Free cash flow 2016–2025
KIORA PHARMACEUTICALS, INC. (KPHMW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.1MFY2025 · since FY2016: -$8.4M → -$10.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.1M | -217.8% |
| FY2024 | $8.6M | +189.5% |
| FY2023 | -$9.6M | +8.4% |
| FY2022 | -$10.4M | +2.9% |
| FY2021 | -$10.7M | -46.4% |
| FY2020 | -$7.3M | +10.0% |
| FY2019 | -$8.2M | +24.9% |
| FY2018 | -$10.9M | -67.0% |
| FY2017 | -$6.5M | +22.7% |
| FY2016 | -$8.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KPHMW financial trends
KPHMW RevenueKPHMW Net incomeKPHMW Net marginKPHMW Gross profitKPHMW Gross marginKPHMW Operating incomeKPHMW Operating marginKPHMW Operating cash flowKPHMW Capital expendituresKPHMW Return on equityKPHMW Stock buybacksKPHMW Dividends paidKPHMW Total assetsKPHMW Total liabilitiesKPHMW Shareholders’ equityKPHMW overview →